Delivery Order SPE2DB20D3505-SPE2DB22FT3Y6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,092.77 firm fixed-price delivery order is for LOKELMA 10 GRAM POWDER PACKET 30S, with a completion date of November 28, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is a firm fixed price delivery order worth $2,435.52, granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract is for the provision of LOKELMA 10 GRAM POWDER PACKET 30S, a pharmaceutical product, with a completion date of February 22, 2024. Amerisourcebergen Drug Corp has received numerous prior awards from DLA Troop Support Medical to supply pharmaceuticals, medical...
- This federal contract award is a delivery order (SPE2DB22D1106|SPE2DB24FELF5) from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $10,026.42 firm fixed price contract is for the supply of LOKELMA 10 GRAM POWDER PACKET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 15, 2024 and was awarded on April 12, 2024. There is no set-aside designation for this contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,239.06 firm-fixed-price delivery order is for the supply of LOKELMA 5 GRAM POWDER PACKET 30S, a medical product, with a completion date of October 25, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,795.77, is for the delivery of LOKELMA 10 GRAM POWDER PACKET 11S, a specialty medication. The award is a Delivery Order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,691.76 firm fixed-price delivery order is for the supply of LOKELMA 10 gram powder packets, a pharmaceutical product. The contract has a completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Lokelma 10 gram powder packets. The contract is a Delivery Order with a Firm Fixed Price of $1,713.06 and a completion date of May 15, 2024. Amerisourcebergen, through its Corporate Office division, holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This federal contract award is for the delivery of LOKELMA 10 GRAM POWDER PACKET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,721.26 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 4, 2024 and is a Firm Fixed Price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, valued at $2,745.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LOKELMA 10 GRAM POWDER PACKET 30S, a pharmaceutical product, with a completion date of August 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. The contract is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award, with an ID of SPE2DB20D3101|SPE2DB24FRUW6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,613.41, is for the delivery of LOKELMA 5 GRAM POWDER PACKET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of September 16, 2024. This contract award is not...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT3Y6Delivery Order
This federal contract award, with ID SPE2DB20D3505|SPE2DB22FT3Y6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,167.77 firm fixed-price delivery order is for the supply of LOKELMA 10 GRAM POWDER PACKET 30S, a pharmaceutical product. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. This contract is not set aside for any specific business type. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/14/22 |